State of the art for diagnosis of HIV infection

Clinical Infectious Diseases

Volumn 45, Issue SUPPL. 4, 2007, Pages

  Branson, Bernard M ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

DIAGNOSTIC PROCEDURE; ENZYME IMMUNOASSAY; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COUNSELING; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEROCONVERSION; VIRUS LOAD; VIRUS TRANSMISSION; WESTERN BLOTTING;

AIDS SERODIAGNOSIS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MALE; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; TIME FACTORS;

EID: 40949106494     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522541     Document Type: Review

References (24)

1. Association of Public Health Laboratories. HIV diagnostic testing utilization survey report. 2005. Available at: http://www.aphl.org/ programs/infectious_diseases/hiv/Documents/hiv_survey_report.pdf. Accessed 27 February 2007.
2. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic - United States 2003. MMWR Morb Mortal Wkly Rep 2003; 52:329-32.
3. Hutchinson AB, Branson BM, Kim A, Farmham PG. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS 2006; 20:1597-604.
4. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-9.
5. Marks G, Crepaz N, Senterfitt W, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39:44-53.
6. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-9.
7. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004; 292:219-23.
8. Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated US Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. US Public Health Service. MMWR Recomm Rep 2005; 54(RR-9):1-17.
9. Lyss SB, Branson BM, Kroc KA, Couture EF, Newman DR, Weinstein RA. Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr 2007; 44:435-42.
10. Centers for Disease Control and Prevention (CDC). General and laboratory considerations: rapid HIV tests currently available in the United States. Rev. ed. Atlanta, GA: US Department of Health and Human Services, CDC, 2007. Available at: http://www.cdc.gov/hiv/topics/testing/resources/factsheets/rt-lab. htm. Accessed 19 October 2007.
11. Centers for Disease Control and Prevention. Protocols for confirmation of reactive rapid HIV tests. MMWR Morb Mortal Wkly Rep 2004; 53:221-2.
12. OraQuick Advance Rapid HIV-1/2 Antibody Test [package insert]. Bethlehem, PA: OraSure Technologies, 2004. Available at http://www.orasure.com/ uploaded/398.pdf. Accessed 27 February 2007.
13. Reveal G3 Rapid HIV-1 Antibody Test [package insert]. Halifax, Canada: Medmira Laboratories, 2006. Available at http://www.reveal-hiv.com/pdf/ g3_insert.pdf. Accessed 27 February 2007.
14. Uni-Gold Recombigen HIV [package insert]. Bray, Ireland: Trinity Biotech, 2004. Available at http://www.unigoldhiv.com/package_insert.pdf. Accessed 27 February 2007.
15. Multispot HIV-1/HIV-2 Rapid Test [package insert]. Redmond, WA: Bio-Rad Laboratories, 2004. Available at: http://www.fda.gov/cber/pmalabel/ p040046LB.pdf. Accessed 29 March 2006.
16. Clearview HIV 1/2 Stat-Pak [package insert]. Medford, NY: Chembio Diagnostic Systems, 2007. Available at: http://www.invernessmedicalpd. com/poc/downloads/CLR_HIV_1-2_STAT-PAK_PI_05904.00.pdf. Accessed 27 February 2007.
17. Clearview Complete HIV 1/2 [package insert]. Medford, NY: Chembio Diagnostic Systems, 2007. Available at: http://www.invernessmedicalpd. com/poc/downloads/CLR_COMPLETE_HIV1-2_PI_05901.00.pdf. Accessed 27 February 2007.
18. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006; 8:125-31.
19. Pilcher CD, Fiscus SA, Nguyen TZQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873-83.
20. Aptima HIV-1 RNA Qualitative Assay [package insert]. San Diego, CA: Gen-Probe. Available at http://www.gen-probe.com/pdfs/pi/500238-ARTRevA.pdf. Accessed 27 February 2007.
21. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1infection. N Engl J Med 1998; 339:33-9.
22. Celum CL, Buchbinder SP, Donnell D, et al. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials vaccine preparedness cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis 2001; 183:23-35.
23. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: http://aidsinfo.nih.gov/. Accessed 20 March 2007.
24. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 16:1119-29.